Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$31.87 - $40.71 $1.36 Million - $1.74 Million
42,682 New
42,682 $1.74 Million
Q3 2022

Nov 14, 2022

SELL
$42.27 - $57.6 $3.12 Million - $4.25 Million
-73,810 Reduced 52.63%
66,424 $2.83 Million
Q2 2022

Aug 16, 2022

BUY
$52.3 - $71.59 $6.36 Million - $8.71 Million
121,655 Added 654.8%
140,234 $7.83 Million
Q1 2022

May 17, 2022

BUY
$51.32 - $68.5 $762,615 - $1.02 Million
14,860 Added 399.57%
18,579 $1.15 Million
Q4 2021

Feb 15, 2022

SELL
$47.03 - $57.12 $100,314 - $121,836
-2,133 Reduced 36.45%
3,719 $205,000
Q3 2021

Nov 16, 2021

SELL
$52.17 - $70.2 $329,505 - $443,383
-6,316 Reduced 51.91%
5,852 $308,000
Q2 2021

Aug 16, 2021

SELL
$68.86 - $83.34 $328,668 - $397,781
-4,773 Reduced 28.17%
12,168 $838,000
Q1 2021

May 18, 2021

SELL
$76.15 - $111.94 $2.09 Million - $3.07 Million
-27,392 Reduced 61.79%
16,941 $1.31 Million
Q4 2020

Feb 17, 2021

BUY
$96.85 - $148.25 $1.29 Million - $1.98 Million
13,370 Added 43.18%
44,333 $4.39 Million
Q3 2020

Nov 17, 2020

SELL
$122.47 - $213.56 $3.18 Million - $5.55 Million
-25,996 Reduced 45.64%
30,963 $4.39 Million
Q2 2020

Aug 17, 2020

BUY
$185.52 - $231.25 $8.49 Million - $10.6 Million
45,752 Added 408.24%
56,959 $11.2 Million
Q1 2020

May 15, 2020

SELL
$143.0 - $274.03 $12.1 Million - $23.1 Million
-84,395 Reduced 88.28%
11,207 $2.2 Million
Q4 2019

Feb 14, 2020

BUY
$146.12 - $215.82 $5.26 Million - $7.77 Million
36,008 Added 60.42%
95,602 $19.8 Million
Q3 2019

Nov 14, 2019

BUY
$130.44 - $187.64 $6.67 Million - $9.6 Million
51,147 Added 605.5%
59,594 $9.1 Million
Q2 2019

Aug 15, 2019

BUY
$111.45 - $128.93 $941,418 - $1.09 Million
8,447 New
8,447 $1.09 Million
Q1 2019

May 16, 2019

SELL
$89.61 - $117.78 $4.89 Million - $6.42 Million
-54,536 Closed
0 $0
Q4 2018

Feb 15, 2019

SELL
$87.81 - $110.65 $11.5 Million - $14.5 Million
-130,733 Reduced 70.56%
54,536 $5 Million
Q3 2018

Nov 14, 2018

BUY
$90.63 - $120.22 $11.4 Million - $15.2 Million
126,277 Added 214.06%
185,269 $20.8 Million
Q2 2018

Aug 15, 2018

SELL
$88.4 - $105.34 $2.79 Million - $3.33 Million
-31,594 Reduced 34.88%
58,992 $5.44 Million
Q1 2018

May 15, 2018

SELL
$94.51 - $120.23 $4.41 Million - $5.61 Million
-46,626 Reduced 33.98%
90,586 $9.04 Million
Q4 2017

Feb 15, 2018

BUY
$84.48 - $104.02 $5.4 Million - $6.65 Million
63,958 Added 87.31%
137,212 $12.9 Million
Q3 2017

Nov 14, 2017

BUY
$73.17 - $103.47 $5.36 Million - $7.58 Million
73,254
73,254 $7.45 Million

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.69B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.